Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up

[1] Garb J(2009)Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass Obes Surg 19 1447-1455

[2] Welch G(2018)Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1 year follow-up Obes Surg 28 1342-1350

[3] Zagarins S(2020)Which one is better for non-alcoholic fatty liver disease, the Roux-en-Y gastric bypass or one anastomosis gastric bypass? A paired liver biopsy report Obesity Medicine 18 100205-315

[4] Kuhn J(2020)A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass BMC Surg 20 30-39

[5] Romanelli J(2005)Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients Obes Surg 15 310-2941

[6] Nickel F(2020)Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis Ann Surg 272 32-2712

[7] Tapking C(2020)The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis Obes Surg 30 2935-88

[8] Benner L(2014)The effect of underlying liver disease on short-term outcomes following bariatric surgery Surg Endosc 28 2708-901

[9] Sollors J(1998)Unsuspected cirrhosis discovered during elective obesity operations Arch Surg 133 84-9

[10] Billeter AT(2011)Increased perioperative mortality following bariatric surgery among patients with cirrhosis Clin Gastroenterol Hepatol 9 897-360

[1] Garb J(2009)Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass Obes Surg 19 1447-1455

[2] Welch G(2018)Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1 year follow-up Obes Surg 28 1342-1350

[3] Zagarins S(2020)Which one is better for non-alcoholic fatty liver disease, the Roux-en-Y gastric bypass or one anastomosis gastric bypass? A paired liver biopsy report Obesity Medicine 18 100205-315

[4] Kuhn J(2020)A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass BMC Surg 20 30-39

[5] Romanelli J(2005)Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients Obes Surg 15 310-2941

[6] Nickel F(2020)Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis Ann Surg 272 32-2712

[7] Tapking C(2020)The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis Obes Surg 30 2935-88

[8] Benner L(2014)The effect of underlying liver disease on short-term outcomes following bariatric surgery Surg Endosc 28 2708-901

[9] Sollors J(1998)Unsuspected cirrhosis discovered during elective obesity operations Arch Surg 133 84-9

[10] Billeter AT(2011)Increased perioperative mortality following bariatric surgery among patients with cirrhosis Clin Gastroenterol Hepatol 9 897-360